Using AI to analyze biopsies

Israeli startup Nucleai is developing computer vision and artificial intelligence (AI) to help overworked pathologists process and analyze biopsies for cancer quicker and more accurately. Nucleai founders have years of experience of computer vision gained during their IDF service.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *